Robert Weinstein insider trades
Open-market stock purchases and sales by Robert Weinstein, Director at XWELL, Inc, from SEC Form 4 filings since Aug 20, 2010.
Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +112%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 25, 2026 | XWEL XWELL, Inc | Bought (not open market) | — |
| May 18, 2026 | TAOX TAO Synergies Inc | Bought (not open market) | — |
| Mar 31, 2026 | PMCB PharmaCyte Biotech, Inc | Bought (not open market) | — |
| Mar 31, 2026 | PMCB PharmaCyte Biotech, Inc | Bought (not open market) | — |
| Feb 27, 2026 | XWEL XWELL, Inc | Bought (not open market) | — |
| Dec 12, 2025 | PMCB PharmaCyte Biotech, Inc | Bought (not open market) | — |
| Dec 12, 2025 | PMCB PharmaCyte Biotech, Inc | Sold (not open market) | $34.4K |
Companies traded
- XWEL XWELL, Inc: 2 buys, last Aug 25, 2026
- TAOX TAO Synergies Inc: other filings, last May 18, 2026
- PMCB PharmaCyte Biotech, Inc: other filings, last Mar 31, 2026
- SNPX Synaptogenix, Inc: 1 sale, last Dec 16, 2022
- XSPA XpresSpa Group, Inc: 3 sales, last Apr 20, 2022
- NTRP Neurotrope, Inc: 2 buys, last Dec 1, 2020
- CWDW CDSS Wind Down Inc: other filings, last Aug 20, 2010